SCHEMBL14155125

SCHEMBL14155125

CC(C)(CC(C)(C)n1ncc2ccc(Cl)cc21)NO

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ KMO O15229 8/20 0.46
▸ CYP11B2 P19099 2/20 0.43
▸ SYK P43405 1/20 0.40
▸ CYP11B1 P15538 1/20 0.35
▸ POLB P06746 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ CCR9 P51686 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ HDAC8 Q9BY41 1/20 0.32
▸ TP53 P04637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14155126 0.84 CYP11B1 (0.43) CYP11B2CYP11B1MAPK1
SCHEMBL14155122 0.81 CYP11B1 (0.37) KMOCYP11B2CYP11B1POLBKMT2A
SCHEMBL22357749 0.66 HTR2A (0.36) KMOKMT2AMAPK1
SCHEMBL21733154 0.64 KMO (0.62) KMOCYP11B2SMN1; SMN2TSHRMAPK1
SCHEMBL8253090 0.63 KMO (0.70) KMOCYP11B2SYKKMT2A
SCHEMBL27605138 0.63 CHEK1 (0.38) POLBKMT2AALDH1A1HTT
SCHEMBL8430529 0.62 KMO (0.64) KMOCYP11B2KMT2AALDH1A1CYP1A2
SCHEMBL17454422 0.62 KMO (0.51) KMOCYP11B2POLBSMN1; SMN2ALDH1A1
SCHEMBL20665055 0.61 KMO (0.62) KMOCYP11B2CYP11B1SMN1; SMN2ALDH1A1
SCHEMBL26622638 0.61 CHEK1 (0.36) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1827427-B1 ARYLOXYETHYLAMINE DERIVATIVES WITH A COMBINATION OF PARTIAL DOPAMINE-D2 RECEPTOR AGONISM AND SEROTONIN REUPTAKE INHIBITION SOLVAY PHARM BV (NL) 2008-07-23 — — EP disclosed
Send feedback